Put Options

20 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $64,545 - $113,360
6,500 Added 23.47%
34,200 $352,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $12.83 $206,365 - $355,391
27,700 New
27,700 $354,000
Q1 2022

May 16, 2022

SELL
$9.75 - $14.44 $417,300 - $618,032
-42,800 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$13.17 - $20.94 $385,881 - $613,542
-29,300 Reduced 40.64%
42,800 $609,000
Q3 2021

Nov 12, 2021

BUY
$9.16 - $19.83 $390,216 - $844,757
42,600 Added 144.41%
72,100 $1.4 Million
Q2 2021

Aug 06, 2021

SELL
$7.25 - $10.99 $59,450 - $90,118
-8,200 Reduced 21.75%
29,500 $291,000
Q1 2021

May 14, 2021

BUY
$4.57 - $11.18 $78,147 - $191,178
17,100 Added 83.01%
37,700 $351,000
Q4 2020

Feb 12, 2021

SELL
$3.73 - $5.6 $9,698 - $14,559
-2,600 Reduced 11.21%
20,600 $101,000
Q3 2020

Nov 13, 2020

BUY
$4.32 - $11.7 $100,224 - $271,440
23,200 New
23,200 $102,000
Q2 2020

Aug 13, 2020

SELL
$2.94 - $9.1 $54,390 - $168,350
-18,500 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$2.27 - $6.2 $82,174 - $224,440
-36,200 Reduced 66.18%
18,500 $66,000
Q4 2019

Feb 12, 2020

BUY
$3.46 - $6.93 $692 - $1,386
200 Added 0.37%
54,700 $306,000
Q3 2019

Nov 14, 2019

BUY
$2.69 - $4.85 $51,917 - $93,605
19,300 Added 54.83%
54,500 $193,000
Q2 2019

Aug 20, 2019

SELL
$3.65 - $7.89 $178,850 - $386,610
-49,000 Reduced 58.19%
35,200 $140,000
Q1 2019

May 15, 2019

SELL
$7.08 - $12.09 $242,136 - $413,478
-34,200 Reduced 28.89%
84,200 $616,000
Q4 2018

Feb 14, 2019

BUY
$8.14 - $13.28 $446,886 - $729,072
54,900 Added 86.46%
118,400 $1.02 Million
Q3 2018

Nov 14, 2018

BUY
$11.85 - $16.0 $270,180 - $364,800
22,800 Added 56.02%
63,500 $787,000
Q1 2018

May 15, 2018

BUY
$14.65 - $19.9 $231,470 - $314,420
15,800 Added 63.45%
40,700 $808,000
Q4 2017

Feb 14, 2018

BUY
$17.3 - $24.08 $108,990 - $151,704
6,300 Added 33.87%
24,900 $466,000
Q3 2017

Nov 15, 2017

BUY
$15.2 - $21.5 $282,720 - $399,900
18,600
18,600 $400,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.66B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.